Contraceptive Drugs Market with COVID-19 Impact Analysis, by Product (Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives), by Distribution Channel (Hospitals, Clinics, Retail Pharmacy, Online Channel, Public Channel & NGOs, and Others), by End-user (Homecare, Hospitals, and Clinics), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Contraceptive Drugs Market size was valued at USD 17,501.01 Million in 2022, expanding at a CAGR of 7.67% from 2023 to 2030.
Pharmaceuticals known as contraceptives are used to delay or control the reproductive process in order to avoid becoming pregnant. They are available as oral tablets, injections, patches, and intrauterine devices (IUDs), among other forms. These medications function in various ways, such as by inhibiting ovulation, thickening cervical mucus to restrict sperm motility, or changing the uterine lining to hinder embryo implantation. With the use of contraceptive medications, both individuals and couples may regulate their fertility in an effective and reversible manner, empowering them to make decisions about family planning and reproductive health.
Contraceptive Drugs Market- Market Dynamics
- Increasing Prevalence of sexually transmitted illnesses to propel market demand
Due to continued population growth and an increase in the prevalence of STDs, governmental entities have been obliged to implement severe birth control policies. Several governmental and non-governmental organizations have launched a variety of family planning and pregnancy prevention initiatives. Organizations including gynecologist divisions, family planning organizations, women\'s health management organizations, and birth control groups have started beneficial initiatives on appropriate and sufficient contraceptives. Traditional therapies and drugs have a lower rate of effectiveness than modern methods, and they offer only minimal STD prevention. As a result, the general populace is increasingly adopting and using modern technologies like tablets, sterilization, and other products.
Contraceptive Drugs Market- Key Insights
- As per the analysis shared by our research analyst, the global Contraceptive Drugs market is estimated to grow annually at a CAGR of around 7.67% over the forecast period (2023-2030).
- The Contraceptive Drugs industry is projected to grow at a significant rate due to the increasing Prevalence of sexually transmitted illnesses
- Based on Product segmentation, oral contraceptive pills was predicted to show maximum market share in the year 2022
- Based on Distribution Channel segmentation, retail pharmacy was the leading type in 2022
- Based on end-user segmentation, homecare was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Contraceptive Drugs Market- Segmentation Analysis:
The Global Contraceptive Drugs Market is segmented on the basis of Product, Distribution channel, Distribution channel, and Region.
The market is divided into categories based on Product: Oral Contraceptive Pills, Injectable Contraceptives, and Topical Contraceptives. The oral category has the largest market share due to the increased use of oral medications in both developed and developing nations worldwide. The excessive clinical advantages of oral medications over other forms of contraception, such as injectables and patches, are to blame for the spike in demand.
The market is divided into categories based on distribution channels: Hospitals, Clinics, Retail Pharmacy, Online Channel, Public Channel & NGOs, and Others. The global market was controlled by the retail pharmacy sector. The general public\'s rising demand for OTC contraceptives and greater awareness of various contraceptive options are credited with driving the retail pharmacy segment\'s dominance.
Contraceptive Drugs Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is likely to lead the market. The US has a sizable stake in North America because of its market dominance and the region\'s high level of understanding about contraceptive pills. For instance, the birth control pill is the type of birth control that is most often prescribed in the United States, and 25% of women between the ages of 15 and 44 who are currently using contraceptive methods said that they preferred to use the pill.
Contraceptive Drugs Market- Competitive Landscape:
Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Products makers compete on a variety of aspects, including product costs, performance, product making, Distribution channel, reputation, and availability. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in November 2022, The U.S. Food & Drug Administration (FDA) granted provisional approval to Lupin\'s Abbreviated New Drug Application (ANDA), Drospirenone Drugs, 4 mg, allowing it to sell a generic version of Slynd Tablets, 4 mg, of Exeltis USA Inc. Drospirenone tablets (RLD Slynd) were anticipated to generate USD 141 million in annual sales in the US.
Recent Developments:
- In October 2022, Gedeon Richter stated that Drovelis (E4/DRSP) was made accessible as a combined oral contraceptive in the UK. When considering whether to prescribe it, the doctor considers the woman\'s current risk factors, particularly those for venous thromboembolism. This comment was made around a year after the Medicines and Healthcare products Regulatory Agency (MHRA) granted the UK license for E4/DRSP.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CONTRACEPTIVE DRUGS MARKET KEY PLAYERS
- Teva Pharmaceuticals
- Pfizer Inc.
- Novartis Pharmaceuticals
- Mylan N.V. (now part of Viatris Inc.)
- Merck & Co., Inc.
- Lupin Limited
- Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson)
- Glenmark Pharmaceuticals
- Ferring Pharmaceuticals
- Evofem Biosciences
- CooperSurgical, Inc. (acquired by The Cooper Companies)
- Church & Dwight Co., Inc. (maker of Trojan condoms)
- Bayer AG
- Allergan (now part of AbbVie)
- Agile Therapeutics
GLOBAL CONTRACEPTIVE DRUGS MARKET, BY PRODUCT
- Oral Contraceptive Pills
- Injectable Contraceptives
- Topical Contraceptives
GLOBAL CONTRACEPTIVE DRUGS MARKET, BY DISTRIBUTION CHANNEL
- Hospitals
- Clinics
- Retail Pharmacy
- Online Channel
- Public Channel & NGOs
- Others
GLOBAL CONTRACEPTIVE DRUGS MARKET, BY END-USER
- Homecare
- Hospitals
- Clinics
GLOBAL CONTRACEPTIVE DRUGS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
Rest of MEA
TABLE OF CONTENT
1. Contraceptive Drugs Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Contraceptive Drugs Market Snippet by Product
2.1.2. Contraceptive Drugs Market Snippet by Distribution Channel
2.1.3. Contraceptive Drugs Market Snippet by End-user
2.1.4. Contraceptive Drugs Market Snippet by Country
2.1.5. Contraceptive Drugs Market Snippet by Region
2.2. Competitive Insights
3. Contraceptive Drugs Key Market Trends
3.1. Contraceptive Drugs Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Contraceptive Drugs Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Contraceptive Drugs Market Opportunities
3.4. Contraceptive Drugs Market Future Trends
4. Contraceptive Drugs Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Contraceptive Drugs Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Contraceptive Drugs Market Landscape
6.1. Contraceptive Drugs Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Contraceptive Drugs Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
7.1.2. Oral Contraceptive Pills
7.1.3. Injectable Contraceptives
7.1.4. Topical Contraceptives
8. Contraceptive Drugs Market – By Distribution Channel
8.1. Overview
8.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
8.1.2. Hospitals
8.1.3. Clinics
8.1.4. Retail Pharmacy
8.1.5. Online Channel
8.1.6. Public Channel & NGOs
8.1.7. Others
9. Contraceptive Drugs Market – By End-user
9.1. Overview
9.1.1. Segment Share Analysis, By End-user, 2022 & 2030 (%)
9.1.2. Homecare
9.1.3. Hospitals
9.1.4. Clinics
10. Contraceptive Drugs Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Contraceptive Drugs Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Contraceptive Drugs Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Contraceptive Drugs Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Contraceptive Drugs Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Contraceptive Drugs Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Contraceptive Drugs Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Teva Pharmaceuticals
11.2.2. Pfizer Inc.
11.2.3. Novartis Pharmaceuticals
11.2.4. Mylan N.V. (now part of Viatris Inc.)
11.2.5. Merck & Co., Inc.
11.2.6. Lupin Limited
11.2.7. Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson)
11.2.8. Glenmark Pharmaceuticals
11.2.9. Ferring Pharmaceuticals
11.2.10. Evofem Biosciences
11.2.11. CooperSurgical, Inc. (acquired by The Cooper Companies)
11.2.12. Church & Dwight Co., Inc. (maker of Trojan condoms)
11.2.13. Bayer AG
11.2.14. Allergan (now part of AbbVie)
11.2.15. Agile Therapeutics
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
